The FDA possesses the legal authority, institutional framework, and technical expertise necessary to solve this problem. What is missing is leadership’s willingness to demand the standards that once defined American drug regulation and legacy records of a low number of recalls.
FDA Leadership’s “Blind Spots” Leads to a Surge in Medical Device and Drug Recalls Continue Reading
To believe it, given that it involves an enormous number of people, institutions, medical societies, scientific bodies all in sync to cover up and steer people away from valid treatments, you have to believe something else: that humanity doesn’t care.
Buried Before Ivermectin: Meet Chlorine Dioxide Continue Reading
Unless this system is forced into the open, selective reporting will continue to be standard practice in even the most prestigious journals. And the public will keep receiving a polished marketing story instead of the full scientific truth.
Major Journal under Fire for Omitting Pfizer’s Failed Flu Data in Seniors Continue Reading
Predictably, Moderna has secured up to $60 million from the Coalition for Epidemic Preparedness Innovations (CEPI) to accelerate development of an Ebola “vaccine” amid an ongoing outbreak in eastern Democratic Republic of Congo.
Moderna Is Building a Modified mRNA “Vaccine” for Ebola Bundibugyo Continue Reading
Given that life expectancy in this country has stagnated over the past 12-15 years, and it is universally acknowledged that chronic disease has risen, it’s past time that we step back and take a hard look at what we’ve done.
Detours and Missteps on the Road to Medical Advances Continue Reading
From the vaccine debate, we have learned that if government agencies truly want to promote the greater good, then best practice would be to take all of the differences among the various demographic groups in the population into consideration.
Inside the Great Vaccine Debate Continue Reading
I began to recognize that from the 1960s through the end of the 20th century, there were a series of illnesses that I initially referred to as ‘fad’ diseases. I now refer to these conditions as ‘meme’ diseases.
The Rise of the Meme Disease Continue Reading
Some clinicians and public-health researchers would argue that the media narrative minimizes known and proven downsides of these drugs, often trivializing or ignoring serious harms, including risks of stroke, blood clots, gallbladder disease, and increased breast cancer risk.
The Biggest Breast Cancer Advance in the Last Twenty Years Continue Reading
Brownstone Institute’s work needs your support. So many institutions have failed over these six years but the work of Brownstone, that only you make possible, stands out for credibility, integrity, and effectiveness. In our times, your support is more important than ever.
Don’t Be Locked Down Continue Reading
If this Hantavirus outbreak proves to be a genuine threat, the key research will be to examine the genome of the virus in question for evidence of gain-of-function manipulation. This is by far the most likely reason for any human-to-human transmission.
Is This Hantavirus a Bioweapon? Continue Reading
The same week that our drug regulator, Health Canada, approved the first generic version of semaglutide—the active ingredient in weight-loss drug Ozempic—a major medical journal published findings highlighting the medication’s troubling connection to eating disorders.
The Ozempic Paradox Continue Reading
Who precisely is directing and producing this sequel? All the ingredients are here for an Academy Award: rodents, long latency, spread through casual contact with the dead, workers in hazmat suits, no known cure, a vaccine in rushed development.
Hantavirus: Stop the Spread Is Back Continue Reading
Search 3,000+ articles & events
